Creatinine Clearance Calculator
Creatinine Clearance Calculator
This calculator estimates creatinine clearance (CrCl) using the Cockcroft-Gault formula, from age, body weight, sex, and serum creatinine. It is the calculation most commonly embedded in drug-dosing tables — the estimate clinicians use to adjust doses of many medications that are cleared by the kidneys.
Creatinine clearance estimates how well the kidneys filter creatinine, a waste product of muscle metabolism. The Cockcroft-Gault equation, published in 1976 by Donald Cockcroft and Henry Gault, was derived from a study of 249 patients aged 18 to 92 and predicts creatinine clearance from age, weight, sex, and serum creatinine. It includes a 15% reduction for females, reflecting their typically lower muscle mass relative to body weight[cockcroft-gault-1976].
The distinction from estimated GFR (eGFR) matters. eGFR (typically the CKD-EPI equation) is normalized to a standard body surface area of 1.73 m² and is the recommended measure for staging chronic kidney disease. Cockcroft-Gault, by contrast, is not normalized — it uses actual body weight and returns a value in mL/min that reflects the individual's size. This makes it the formula historically used for dosing renally-cleared drugs, because a drug dose depends on the actual clearance capacity, not a size-normalized value[cockcroft-gault-1976][niddk-ckd].
This is an educational tool, not a diagnosis. Drug dosing decisions must be made by a qualified healthcare professional using the complete clinical picture.
Enter age, weight, sex, and serum creatinine, and the result updates instantly.
- Age (years) — Cockcroft-Gault is validated in adults.
- Weight (kg) — uses actual body weight (not ideal/adjusted, not normalized).
- Serum creatinine (mg/dL) — from a recent blood test. If your lab reports in μmol/L, divide by 88.4 to get mg/dL.
- Sex — applies the 0.85 female factor.
Example 1 — the standard case. Male, 70 years, 80 kg, serum creatinine 1.5 mg/dL. CrCl = ((140 − 70) × 80) / (72 × 1.5) = 5600 / 108 = 51.9 mL/min (no female factor).
Example 2 — female. Female, 70 years, 80 kg, serum creatinine 1.5 mg/dL. CrCl = 51.9 × 0.85 = 44.1 mL/min. The female factor reduces the estimate because of lower average muscle mass relative to weight[cockcroft-gault-1976].
Example 3 — younger adult. Male, 40 years, 75 kg, serum creatinine 1.0 mg/dL. CrCl = ((140 − 40) × 75) / (72 × 1.0) = 7500 / 72 = 104.2 mL/min — a normal clearance for a younger adult.
The Cockcroft-Gault equation estimates creatinine clearance in mL/min:
where the sex factor is 0.85 for females and 1.0 for males[cockcroft-gault-1976].
Important: this formula requires serum creatinine in mg/dL. If your lab reports creatinine in μmol/L, convert by dividing by 88.4 before entering it.
Why Cockcroft-Gault is not the same as eGFR
The Cockcroft-Gault result is not normalized to body surface area. It reflects the individual's actual clearance capacity, scaled by their real body weight. By contrast, the CKD-EPI equation returns eGFR in mL/min/1.73 m² — normalized to a standard body size so it can be compared across people[inker-2021].
This distinction drives the two uses:
- Drug dosing — historically based on Cockcroft-Gault, because a renally-cleared drug's dose depends on the person's actual clearance.
- CKD staging — based on eGFR (CKD-EPI), normalized for comparability. The National Kidney Foundation provides the reference ranges and staging guidance for eGFR[nkf-egfr].
The choice of formula can change the clinical interpretation. A 45-year-old woman weighing 70 kg with creatinine 1.0 mg/dL has a Cockcroft-Gault CrCl of ~79 mL/min but a CKD-EPI eGFR of ~71 mL/min/1.73 m² — two different numbers answering two different questions[inker-2021].
The practical consequence is that the two measures can place a patient in different drug-dosing buckets. Consider an older, larger adult: a 78-year-old man weighing 95 kg with creatinine 1.4 mg/dL has a Cockcroft-Gault CrCl of about 58 mL/min but a CKD-EPI eGFR of roughly 55 mL/min/1.73 m² — similar, but not identical. In a leaner, older patient the gap widens, because Cockcroft-Gault is sensitive to body weight while CKD-EPI is normalized to a standard body size. Drug labels that specify dosing by "CrCl 30–50" versus "eGFR 30–50" are not interchangeable; using the wrong measure can lead to under- or over-dosing a renally-cleared drug. This is why knowing which formula a reference assumes, and entering accurate weight and creatinine, is essential[awdishu-2025].
A note on current guidance (KDIGO 2024)
KDIGO 2024 recommends the race-free CKD-EPI equation (not Cockcroft-Gault) for drug dosing when precision matters, and recommends eGFR-based dosing over creatinine clearance in many settings[awdishu-2025][kdigo-2024]. However, Cockcroft-Gault remains embedded in many drug-label dosing tables and is still widely used in clinical practice, so it remains worth calculating and understanding. The GFR Calculator provides the CKD-EPI estimate for staging; this calculator provides the Cockcroft-Gault estimate for dosing context.
Step 1 — gather inputs. Age 70, weight 80 kg, serum creatinine 1.5 mg/dL, male.
Step 2 — compute the numerator. (140 − 70) × 80 = 70 × 80 = 5600.
Step 3 — compute the denominator. 72 × 1.5 = 108.
Step 4 — divide. 5600 / 108 = 51.9 mL/min.
Step 5 — apply the sex factor. Male → × 1.0 → 51.9 mL/min.
Step 6 — interpret. A CrCl of ~52 mL/min suggests moderately reduced renal clearance. For drug dosing, many references use ranges (e.g., >50, 30–50, <30 mL/min) to guide dose adjustment — a clinician applies the relevant drug's specific criteria[fda-renal].
The table shows how creatinine clearance changes with age, weight, sex, and creatinine (serum creatinine 1.0 mg/dL unless noted):
| Age | Weight (kg) | Sex | CrCl (mL/min) | Note |
|---|---|---|---|---|
| 40 | 75 | Male | 104.2 | Younger adult, normal |
| 55 | 75 | Male | 88.5 | Declining with age |
| 70 | 80 | Male | 77.8 | Older adult |
| 70 | 80 | Female | 66.1 | Female factor 0.85 |
| 70 | 80 | Male (Scr 1.5) | 51.9 | Higher creatinine |
| 70 | 60 | Male | 58.3 | Lower weight |
Two patterns stand out. First, clearance declines with age — the (140 − age) term means each year of age lowers the estimate. Second, the female factor (0.85) and a higher serum creatinine both reduce the estimate substantially, which is why weight and accurate creatinine matter so much for drug dosing[cockcroft-gault-1976].
- Use real body weight — usually. Cockcroft-Gault was derived with actual body weight. At extremes of obesity or cachexia, ideal or adjusted body weight may be more appropriate; many references advise adjusted weight for BMI >30[fda-renal].
- Convert units first. The formula requires creatinine in mg/dL. If your lab uses μmol/L, divide by 88.4. A unit error changes the result by ~88×.
- Know which formula is being used. CrCl (Cockcroft-Gault) and eGFR (CKD-EPI) are different numbers answering different questions. Dosing tables usually specify which one they assume — match them[awdishu-2025].
- Requires steady-state creatinine. The formula is invalid in acute kidney injury or rapidly changing kidney function, where creatinine has not reached equilibrium[niddk-ckd].
- Not validated under 18. Cockcroft-Gault was derived in adults; pediatric kidney function is estimated differently.
- KDIGO 2024 prefers CKD-EPI for staging and increasingly for dosing. Use this calculator for context, but follow current institutional guidance on which formula to apply for a specific drug[kdigo-2024].
- Match the dosing-table units. A dosing table that says "reduce dose if CrCl < 30" is almost always referring to Cockcroft-Gault in mL/min; one that says "eGFR < 30" refers to CKD-EPI in mL/min/1.73 m². Read the drug's label to see which measure it uses, and enter the matching inputs[fda-renal].
- Re-check creatinine on changes in status. Because the formula requires a steady state, a creatinine drawn during an acute illness or after starting or stopping a medication that affects it may not reflect the patient's baseline. A clinician should re-evaluate with a fresh creatinine when kidney function may have changed[niddk-ckd].
- It is not a diagnosis and not a dosing order. It estimates creatinine clearance; it does not recommend a specific drug dose. Dose adjustment requires a clinician applying the drug's approved criteria[fda-renal].
- Cockcroft-Gault is not normalized to body surface area. It overestimates clearance in obesity and underestimates it in low muscle mass, because it depends on total body weight.
- It assumes a steady state. In acute kidney injury, rapidly changing creatinine, or unstable patients, the estimate is unreliable[niddk-ckd].
- It predates modern creatinine standardization. Cockcroft-Gault was developed before IDMS-calibrated creatinine assays; modern CKD-EPI is calibrated to IDMS standards, so results may differ between the two formulas for the same patient[inker-2021].
- KDIGO 2024 recommends CKD-EPI over Cockcroft-Gault in many settings. This calculator is provided for the many drug tables that still reference Cockcroft-Gault, but it is not the preferred general measure of kidney function[kdigo-2024].
- Not for children, pregnancy, or extremes of body habitus without clinician guidance. Pediatric renal function is estimated with age-adjusted equations, and pregnancy changes kidney function substantially.
- ❓ What is creatinine clearance?
- ✅ Creatinine clearance estimates how well the kidneys filter creatinine, a waste product of muscle metabolism. It is expressed in mL/min and is used primarily for dosing drugs that are cleared by the kidneys. The Cockcroft-Gault formula estimates it from age, weight, sex, and serum creatinine.
- ❓ What is the Cockcroft-Gault formula?
- ✅ CrCl = ((140 − age) × weight in kg) / (72 × serum creatinine in mg/dL), multiplied by 0.85 for females and 1.0 for males. It was published in 1976 and is widely used in drug-dosing tables.
- ❓ What is the difference between creatinine clearance and eGFR?
- ✅ Creatinine clearance (Cockcroft-Gault) is not normalized to body surface area and reflects actual clearance for drug dosing. eGFR (CKD-EPI) is normalized to 1.73 m² and is used for staging chronic kidney disease. They answer different clinical questions and can give different numbers.
- ❓ Why is there a female factor in Cockcroft-Gault?
- ✅ Because, on average, females have lower muscle mass relative to body weight, and creatinine comes from muscle. The original study found creatinine clearance about 15% lower in females, so the formula applies a 0.85 factor.
- ❓ What is a normal creatinine clearance?
- ✅ There is no single 'normal' value; clearance declines with age and varies with body size. Younger adults often have CrCl around 90–140 mL/min. Because it is not normalized, interpreting it requires the individual's context. Drug-dosing ranges (e.g., >50, 30–50, <30 mL/min) are what matter for dosing.
- ❓ Should I use Cockcroft-Gault or CKD-EPI for drug dosing?
- ✅ Many drug labels still reference Cockcroft-Gault, so it remains clinically used. However, KDIGO 2024 recommends the race-free CKD-EPI equation for drug dosing when precision matters, and increasingly recommends eGFR-based dosing. Follow current institutional guidance.
- ❓ How do I convert creatinine from μmol/L to mg/dL?
- ✅ Divide by 88.4. The Cockcroft-Gault formula requires serum creatinine in mg/dL; if your lab reports μmol/L, convert before entering the value. A unit error changes the result by roughly 88×.
- ❓ Is this calculator for dosing medications?
- ✅ No. This is an educational tool that estimates creatinine clearance; it does not recommend specific drug doses. Medication dosing must be determined by a qualified healthcare professional applying the drug's approved criteria to the full clinical picture.
References
- [1]Cockcroft, D.W., & Gault, M.H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31–41.
- [2]Inker, L.A., et al. (2021). New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. New England Journal of Medicine, 385, 1737–1749.
- [3]Kidney Disease: Improving Global Outcomes (KDIGO). (2024). Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S).
- [4]Awdishu, L., et al. (2025). KDIGO 2024 CKD guideline: implications for pharmacy practice. American Journal of Health-System Pharmacy, 82, 660–671.
- [5]U.S. Food and Drug Administration. (2024). Pharmacokinetics in Patients with Impaired Renal Function.
- [6]National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2026). Chronic Kidney Disease: Tests & Diagnosis.
- [7]National Kidney Foundation. (2026). Estimated GFR (eGFR).
Last updated: August 17, 2026
UnByte — Independent Software Engineering
Every calculator references authoritative sources — Editorial policy
